Sphera Funds Management »

Traws Pharma shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Traws Pharma (TRAW) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Traws Pharma

Tip: Access up to 7 years of quarterly data

All positions including Traws Pharma held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Traws Pharma by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $336k 399k 0.84

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Tower Semiconductor Shs New (TSEM)
Cytokinetics Com New (CYTK)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Syndax Pharmaceuticals (SNDX)
Ultragenyx Pharmaceutical (RARE)
BioMarin Pharmaceutical (BMRN)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
NOVA MEASURING Instruments L (NVMI)
Insmed Com Par $.01 (INSM)
Maze Therapeatics (MAZE)
Astrazeneca Ord (AZN)

View all positions for Sphera Funds Management

Top funds holding Traws Pharma

OrbiMed Advisors
Ally Bridge Group
Adage Capital Partners GP
ADAR1 Capital Management
Lynx1 Capital Management
Ikarian Capital
Sphera Funds Management
Vanguard Capital Management
Jane Street
Alyeska Investment Group
Boothbay Fund Management
Geode Capital Management
Hrt Financial
Kynam Capital Management
Dauntless Investment Group

View all funds holding Traws Pharma